Introduction: L-carnitine (LC) has yielded relevant results on ischaemic/ reperfusion (I/R) injuries in organs such as the intestine, liver,
kidney, brain and heart, because of its antioxidant activity. We aimed to evaluate the potential of using L-carnitine to improve the
quality of grafted ovarian tissues. Materials and methods: The ovaries from 4-6-week old mice were grafted into back muscle site.
Transplanted ovaries were divided into four groups. 200 mg/kg LC was injected intraperitoneally one day before surgical operation and repeated until one week after grafting. Follicular morphology and apoptosis were examined in all groups and compared to agematched
non grafted ovaries. Anti- active caspase-3 staining was performed to evaluate apoptosis in all groups. Results: group
Morphological analysis revealed that the number of follicles decreased in all transplanted groups compared with non-grafted group.
The rate of apoptosis in LC- treated group showed no significant differences compared with control. Conclusion: LC supplementation
may be a suitable approach for the ovarian graft viability. Further experimental studies are required to clarify the mechanisms of
action of L-carnitine, and clinical studies are required to determine optimum dose and treatment duration for decreasing I/ R
injuries.
Keywords: Apoptosis, Follicle, L-carnitine, ovarian transplantation